128 related articles for article (PubMed ID: 25744071)
1. [Comparison of differentiated thyroid carcinoma staging systems in a Spanish population].
Andía Melero VM; Martín de Santa-Olalla Llanes M; Sambo Salas M; Percovich Hualpa JC; Motilla de la Cámara M; Collado Yurrita L
Endocrinol Nutr; 2015 Apr; 62(4):152-60. PubMed ID: 25744071
[TBL] [Abstract][Full Text] [Related]
2. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
[TBL] [Abstract][Full Text] [Related]
3. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
Wong RM; Bresee C; Braunstein GD
Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
[TBL] [Abstract][Full Text] [Related]
4. Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.
D'Avanzo A; Ituarte P; Treseler P; Kebebew E; Wu J; Wong M; Duh QY; Siperstein AE; Clark OH
Thyroid; 2004 Jun; 14(6):453-8. PubMed ID: 15242573
[TBL] [Abstract][Full Text] [Related]
5. AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.
Voutilainen PE; Siironen P; Franssila KO; Sivula A; Haapiainen RK; Haglund CH
Anticancer Res; 2003; 23(5b):4283-8. PubMed ID: 14666639
[TBL] [Abstract][Full Text] [Related]
6. Are prognostic scoring systems of value in patients with follicular thyroid carcinoma?
Ríos A; Rodríguez JM; Ferri B; Matínez-Barba E; Febrero B; Parrilla P
Eur J Endocrinol; 2013 Dec; 169(6):821-7. PubMed ID: 24050927
[TBL] [Abstract][Full Text] [Related]
7. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the NTCTCS Staging Systems for Differentiated Thyroid Cancer, Including Age at Diagnosis.
McLeod DS; Jonklaas J; Brierley JD; Ain KB; Cooper DS; Fein HG; Haugen BR; Ladenson PW; Magner J; Ross DS; Skarulis MC; Steward DL; Xing M; Litofsky DR; Maxon HR; Sherman SI
Thyroid; 2015 Oct; 25(10):1097-105. PubMed ID: 26203804
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.
Jukkola A; Bloigu R; Ebeling T; Salmela P; Blanco G
Endocr Relat Cancer; 2004 Sep; 11(3):571-9. PubMed ID: 15369456
[TBL] [Abstract][Full Text] [Related]
10. Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.
Lang B; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 May; 14(5):1551-9. PubMed ID: 17318278
[TBL] [Abstract][Full Text] [Related]
11. A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example.
Brierley JD; Panzarella T; Tsang RW; Gospodarowicz MK; O'Sullivan B
Cancer; 1997 Jun; 79(12):2414-23. PubMed ID: 9191532
[TBL] [Abstract][Full Text] [Related]
12. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
13. Staging systems for papillary thyroid carcinoma: a review and comparison.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2007 Mar; 245(3):366-78. PubMed ID: 17435543
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.
Lundgren CI; Hall P; Dickman PW; Zedenius J
Cancer; 2006 Feb; 106(3):524-31. PubMed ID: 16369995
[TBL] [Abstract][Full Text] [Related]
15. Staging systems for papillary thyroid carcinoma: a study of 2 tertiary referral centers.
Lang BH; Chow SM; Lo CY; Law SC; Lam KY
Ann Surg; 2007 Jul; 246(1):114-21. PubMed ID: 17592299
[TBL] [Abstract][Full Text] [Related]
16. [Differentiated thyroid cancer--staging and prognostic systems].
Dănilă R; Andriescu L; Grigorovici A; Dragomir C; Găluşcă B; Vulpoi C; Ungureanu C; Mogoş V
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):71-6. PubMed ID: 16607831
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
18. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.
Sherman SI; Brierley JD; Sperling M; Ain KB; Bigos ST; Cooper DS; Haugen BR; Ho M; Klein I; Ladenson PW; Robbins J; Ross DS; Specker B; Taylor T; Maxon HR
Cancer; 1998 Sep; 83(5):1012-21. PubMed ID: 9731906
[TBL] [Abstract][Full Text] [Related]
19. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Endocr Relat Cancer; 2007 Mar; 14(1):29-42. PubMed ID: 17395973
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
